Lipopolysaccharides derived from gram-negative bacterial pool of human gut microbiota promote inflammation and obesity development.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanistic literature without systematic search or primary human data.
PubMed 34726960 · doi:10.1080/08830185.2021.1996573
What was done
This narrative review summarizes literature on the mechanistic pathways through which lipopolysaccharide (LPS) from intestinal Gram-negative bacteria enters the circulatory system and drives chronic low-grade inflammation associated with high-fat diet intake and obesity, while discussing approaches to reduce endogenous endotoxin absorption.
What was found
The abstract reports no numerical data, effect sizes, or statistical metrics. It describes qualitative mechanisms: high-fat diet intake causes gut microbiota disruption, increases intestinal permeability through paracellular absorption and transcellular transport, raises plasma LPS levels, and induces chronic low-grade inflammation associated with obesity.
Why it matters
It outlines the conceptual framework linking dietary fat intake, gut barrier disruption, bacterial endotoxin translocation, and obesity-related metabolic inflammation.
Limits
The abstract provides no original empirical data, quantitative measurements, or systematic review methodology. Specific populations, sample sizes, and detailed intervention characteristics are not described.
Cited by
- supports LPS is the outer covering of gram-negative bacteria that reside in the gut and is an initiator of inflammation.